Lorcaserin: Real World Experience in an Insurance-Based Weight Management Clinic

Scripps Whittier Diabetes Institute

Status: Completed

Conditions: Weight Loss; Overweight; Obesity

Treatments: Drug: Lorcaserin

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT03552107

Lorcaserin

Details and patient eligibility

About

This is a retrospective, descriptive study that involves de-identified data consisting of weight changes, pertinent vital signs and laboratory values influenced by body weight, and healthcare utilization of patients prescribed lorcaserin at The Center for Weight Management at the Scripps Clinic in San Diego, CA.

Full description

All patients who initiated treatment with Lorcaserin during the review period will undergo chart review. The primary endpoint will be weight change in patients on Lorcaserin and average duration of Lorcaserin treatment over time (up to 1 year). Secondary endpoints will include changes in vital signs, liver function, glucose, and lipids. In addition, time on treatment, reasons for discontinuation of medication, and changes in healthcare utilization (to include inpatient and outpatient utilization) will be examined. This is a retrospective, one-arm observational study that will include chart reviews of 157 patients who have been treated in the clinic.

Enrollment: 157 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Received at least one prescription for Lorcaserin treatment
• At least 18 years of age or with guardian/parent able to consent for a minor

Exclusion criteria

• Patient under the age of 18 at time of index date

Trial design

157 participants in 1 patient group

Observational Group - Lorcaserin Treated

Description:

The group in this study will be all patients who initiated therapy with Lorcaserin during the review period.

Treatment:

Drug: Lorcaserin